Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease
Cardiogenetics · 2021
DOI: 10.3390/cardiogenetics11030012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiogenetics, 2021. Verfasst von Marco Migliaccio und 6 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amyloidosis is a group of diseases in which amyloid fibrils build up in tissues, leading to organ dysfunction. Cardiac involvement is observed in immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) and, when it occurs, the prognosis worsens. Cardiac tissue infiltration can lead to restrictive cardiomyopathy with clinical signs of diastolic heart failure, without reduction of ejection fraction (HFpEF). The aim of multiple and less invasive diagnostic tests is to discern peculiar characteristics and reach the diagnosis without performing an invasive endomyocardial biopsy. These diagnostic tools allow early diagnosis, and they are crucial to best benefit from target therapy. In this review article, we describe the mechanism behind amyloid fibril formation, infiltration of tissues, and consequent clinical signs, focusing on the diagnostic tools and the red flags to obtain a diagnosis.
Zitieren
APA
Migliaccio, M., Iodice, F., Mauro, M. D., Iannuzzi, A., Pacileo, R., Caiazza, M., & Esposito, A. (2021). Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease. Cardiogenetics. https://doi.org/10.3390/cardiogenetics11030012
Vancouver
Migliaccio M, Iodice F, Mauro MD, Iannuzzi A, Pacileo R, Caiazza M, et al. Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease. Cardiogenetics. 2021. doi:10.3390/cardiogenetics11030012
BibTeX
@article{Migliaccio2021,
author = {Migliaccio, Marco and Iodice, Franco and Mauro, Marco Di and Iannuzzi, Angela and Pacileo, Roberta and Caiazza, Martina and Esposito, Augusto},
title = {Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease},
journal = {Cardiogenetics},
year = {2021},
doi = {10.3390/cardiogenetics11030012}
}
EUVIMED